Last updated on October 2011

New Alzheimer’s Disease Research

Brief description of study

New Alzheimer’s Disease Research

Detailed Study Description

NeuroTrials Research is conducting a 20-month, placebo-controlled research study evaluating an investigational drug for Alzheimer’s Disease. Study-related exams and study drug are provided at no cost. Qualified participants and caregivers will be compensated for time and travel.

Patient Inclusion Criteria:

  • Age 50-89
  • Diagnosis of probable Alzheimer’s Disease
  • Must have a caregiver capable of attending all study visits.
  • In general good health

Patient Exclusion Criteria:

  • History of seizures, strokes or brain abnormalities

Clinical Study Identifier: TX135500

Contact Investigators or Research Sites near you

Start Over

NeuroTrials Research

NeuroTrials Research
Atlanta, GA USA
  Connect »